News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Viral Genetics Inc. (VRAL) and Scott & White Have Agreed to Develop Clinical Trials Focused on Metabolic Disruption in Cancer Patients



10/14/2010 9:32:52 AM

SAN MARINO, Calif.--(BUSINESS WIRE)--Trials are being organized for a new therapeutic approach to treating cancer, under exclusive license by Viral Genetics, Inc., (Pinksheets: VRAL). According to Scott & White Healthcare Senior Vice President for Research Richard E. Beswick, M.D., who is also assistant dean of research at the Texas A&M Health Science Center College of Medicine, the trials will be conducted at the Glenda Tanner Vasicek Cancer Treatment Center, located at Scott & White in Temple, Texas.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES